Detalhe da pesquisa
1.
Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer.
Psychooncology
; 31(8): 1390-1398, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470512
2.
IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer.
Cancer Res
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843355
3.
Increased glucose availability sensitizes pancreatic cancer to chemotherapy.
Nat Commun
; 14(1): 3823, 2023 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380658
4.
Liver Endothelium Promotes HER3-Mediated Cell Survival in Colorectal Cancer with Wild-Type and Mutant KRAS.
Mol Cancer Res
; 20(6): 996-1008, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276002
5.
Clinical development of IDH1 inhibitors for cancer therapy.
Cancer Treat Rev
; 103: 102334, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34974243
6.
IDO1 Is a Therapeutic Target for Pancreatic Cancer-Associated Depression.
Mol Cancer Ther
; 21(12): 1810-1822, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190971
7.
Wild-type IDH1 inhibition enhances chemotherapy response in melanoma.
J Exp Clin Cancer Res
; 41(1): 283, 2022 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153582
8.
Liver Endothelium Microenvironment Promotes HER3-mediated Cell Growth in Pancreatic Ductal Adenocarcinoma.
J Cancer Sci Clin Ther
; 6(4): 431-445, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644317
9.
Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors.
Nat Cancer
; 3(7): 852-865, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681100
10.
Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma.
Cancer Res Commun
; 1(2): 65-78, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582016
11.
RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer.
Mol Cancer Res
; 17(2): 508-520, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266754
12.
Corrigendum: Metabolic Dependencies in Pancreatic Cancer.
Front Oncol
; 8: 672, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30805300
13.
Metabolic Dependencies in Pancreatic Cancer.
Front Oncol
; 8: 617, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30631752
14.
Editorial: Metabolic regulation under oxidative stress in cancer.
Front Oncol
; 13: 1286086, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37771445
15.
IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.
Mol Cancer Res
; 15(4): 489-497, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096479
16.
Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells.
Cancer Res
; 77(16): 4460-4471, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28652247
17.
GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.
Mol Cell Endocrinol
; 422: 160-171, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26690777